English
简体中文
Total: £ 56.28
Published Date: 2025-06-17 | Pages: 120 | Tables: 120 | Pharma & Healthcare
In 2024, the global market size of Antibody-drug Conjugates was estimated to be worth US$ 3102 million and is forecast to reach approximately US$ 4258 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.
North America is the largest market with about 59% market share. Europe is follower, accounting for about 27% market share.
The key players are ImmunoGen, Seattle Genetics, Roche, Takeda etc. Takeda is the largest manufacturer with about 57% revenue market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antibody-drug Conjugates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody-drug Conjugates.
The Antibody-drug Conjugates market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antibody-drug Conjugates market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody-drug Conjugates manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
ImmunoGen
Seattle Genetics
Roche
Takeda
Segment by Type
Adcetris
Kadcyla
Segment by Application
Breast Cancer
Lymphoma
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Antibody-drug Conjugates in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Antibody-drug Conjugates manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antibody-drug Conjugates sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Antibody-drug Conjugates Product Introduction
1.2 Market by Type
1.2.1 Global Antibody-drug Conjugates Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Adcetris
1.2.3 Kadcyla
1.3 Market by Application
1.3.1 Global Antibody-drug Conjugates Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antibody-drug Conjugates Market Size Estimates and Forecasts
2.1.1 Global Antibody-drug Conjugates Revenue 2020-2031
2.1.2 Global Antibody-drug Conjugates Sales 2020-2031
2.2 Antibody-drug Conjugates Market Size by Region: 2024 Versus 2031
2.3 Antibody-drug Conjugates Sales by Region (2020-2031)
2.3.1 Global Antibody-drug Conjugates Sales by Region: 2020-2025
2.3.2 Global Antibody-drug Conjugates Sales Forecast by Region (2026-2031)
2.3.3 Global Antibody-drug Conjugates Sales Market Share by Region (2020-2031)
2.4 Antibody-drug Conjugates Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Antibody-drug Conjugates Revenue by Region: 2020-2025
2.4.2 Global Antibody-drug Conjugates Revenue Forecast by Region (2026-2031)
2.4.3 Global Antibody-drug Conjugates Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Antibody-drug Conjugates Sales by Type (2020-2031)
3.1.1.1 Global Antibody-drug Conjugates Sales Volume by Type (2020-2031)
3.1.1.2 Global Antibody-drug Conjugates Sales Market Share by Type (2020-2031)
3.1.2 Global Antibody-drug Conjugates Revenue by Type (2020-2031)
3.1.2.1 Global Antibody-drug Conjugates Revenue by Type (2020-2031)
3.1.2.2 Global Antibody-drug Conjugates Revenue Market Share by Type (2020-2031)
3.1.3 Antibody-drug Conjugates Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Antibody-drug Conjugates Sales by Application (2020-2031)
3.2.1.1 Global Antibody-drug Conjugates Sales Volume by Application (2020-2031)
3.2.1.2 Global Antibody-drug Conjugates Sales Market Share by Application (2020-2031)
3.2.2 Global Antibody-drug Conjugates Revenue by Application (2020-2031)
3.2.2.1 Global Antibody-drug Conjugates Revenue by Application (2020-2031)
3.2.2.2 Global Antibody-drug Conjugates Revenue Market Share by Application (2020-2031)
3.2.3 Antibody-drug Conjugates Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Adcetris of Antibody-drug Conjugates Revenue Market Share by Application
3.3.2 Kadcyla of Antibody-drug Conjugates Revenue Market Share by Application
4 Global Antibody-drug Conjugates by Manufacturers
4.1 Global Top Antibody-drug Conjugates Manufacturers by Sales (2020-2025)
4.1.1 Global Antibody-drug Conjugates Sales by Manufacturer (2020-2025)
4.1.2 Global Antibody-drug Conjugates Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Antibody-drug Conjugates Manufacturers by Revenue (2020-2025)
4.2.1 Global Antibody-drug Conjugates Revenue by Manufacturer (2020-2025)
4.2.2 Global Antibody-drug Conjugates Revenue Share by Manufacturer (2020-2025)
4.3 Global Antibody-drug Conjugates Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Antibody-drug Conjugates Manufacturers Covered: Ranking by Revenue
4.4.2 Global Antibody-drug Conjugates Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Antibody-drug Conjugates Manufacturing Base Distribution, Product Type
4.5.1 Antibody-drug Conjugates Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Antibody-drug Conjugates Market
4.5.3 Manufacturers Antibody-drug Conjugates Product Type and Application
4.5.4 Adcetris Market Sales of Antibody-drug Conjugates by Manufacturer
4.5.5 Kadcyla Market Sales of Antibody-drug Conjugates by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 ImmunoGen
5.1.1 ImmunoGen Company Information
5.1.2 ImmunoGen Description, Business Overview
5.1.3 ImmunoGen Antibody-drug Conjugates Products Offered
5.1.4 ImmunoGen Antibody-drug Conjugates Sales, Revenue and Gross Margin (2020-2025)
5.1.5 ImmunoGen Antibody-drug Conjugates Sales by Product in 2024
5.1.6 ImmunoGen Antibody-drug Conjugates Sales by Application in 2024
5.1.7 ImmunoGen Antibody-drug Conjugates Sales by Geographic Area in 2024
5.1.8 ImmunoGen Recent Developments
5.2 Seattle Genetics
5.2.1 Seattle Genetics Company Information
5.2.2 Seattle Genetics Description, Business Overview
5.2.3 Seattle Genetics Antibody-drug Conjugates Products Offered
5.2.4 Seattle Genetics Antibody-drug Conjugates Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Seattle Genetics Antibody-drug Conjugates Sales by Product in 2024
5.2.6 Seattle Genetics Antibody-drug Conjugates Sales by Application in 2024
5.2.7 Seattle Genetics Antibody-drug Conjugates Sales by Geographic Area in 2024
5.2.8 Seattle Genetics Recent Developments
5.3 Roche
5.3.1 Roche Company Information
5.3.2 Roche Description, Business Overview
5.3.3 Roche Antibody-drug Conjugates Products Offered
5.3.4 Roche Antibody-drug Conjugates Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Roche Antibody-drug Conjugates Sales by Product in 2024
5.3.6 Roche Antibody-drug Conjugates Sales by Application in 2024
5.3.7 Roche Antibody-drug Conjugates Sales by Geographic Area in 2024
5.3.8 Roche Recent Developments
5.4 Takeda
5.4.1 Takeda Company Information
5.4.2 Takeda Description, Business Overview
5.4.3 Takeda Antibody-drug Conjugates Products Offered
5.4.4 Takeda Antibody-drug Conjugates Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Takeda Antibody-drug Conjugates Sales by Product in 2024
5.4.6 Takeda Antibody-drug Conjugates Sales by Application in 2024
5.4.7 Takeda Antibody-drug Conjugates Sales by Geographic Area in 2024
5.4.8 Takeda Recent Developments
6 North America
6.1 North America Antibody-drug Conjugates Market Size YoY Growth 2020-2031
6.2 North America Antibody-drug Conjugates Market Facts & Figures by Country
6.2.1 North America Antibody-drug Conjugates Sales by Country (2020-2031)
6.2.2 North America Antibody-drug Conjugates Revenue by Country (2020-2031)
6.3 North America Antibody-drug Conjugates Sales by Type (2020-2025)
6.4 North America Antibody-drug Conjugates Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Antibody-drug Conjugates Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Antibody-drug Conjugates Market Facts & Figures by Region
7.2.1 Asia-Pacific Antibody-drug Conjugates Sales by Region (2020-2031)
7.2.2 Asia-Pacific Antibody-drug Conjugates Revenue by Region (2020-2031)
7.3 Asia-Pacific Antibody-drug Conjugates Sales by Type (2020-2025)
7.4 Asia-Pacific Antibody-drug Conjugates Sales by Application (2020-2025)
8 Europe
8.1 Europe Antibody-drug Conjugates Market Size YoY Growth 2020-2031
8.2 Europe Antibody-drug Conjugates Market Facts & Figures by Country
8.2.1 Europe Antibody-drug Conjugates Sales by Country (2020-2031)
8.2.2 Europe Antibody-drug Conjugates Revenue by Country (2020-2031)
8.3 Europe Antibody-drug Conjugates Sales by Type (2020-2025)
8.4 Europe Antibody-drug Conjugates Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Antibody-drug Conjugates Market Size YoY Growth 2020-2031
9.2 Latin America Antibody-drug Conjugates Market Facts & Figures by Country
9.2.1 Latin America Antibody-drug Conjugates Sales by Country (2020-2031)
9.2.2 Latin America Antibody-drug Conjugates Revenue by Country (2020-2031)
9.3 Latin America Antibody-drug Conjugates Sales by Type (2020-2025)
9.4 Latin America Antibody-drug Conjugates Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Antibody-drug Conjugates Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Antibody-drug Conjugates Market Facts & Figures by Country
10.2.1 Middle East and Africa Antibody-drug Conjugates Sales by Country (2020-2031)
10.2.2 Middle East and Africa Antibody-drug Conjugates Revenue by Country (2020-2031)
10.3 Middle East and Africa Antibody-drug Conjugates Sales by Type (2020-2025)
10.4 Middle East and Africa Antibody-drug Conjugates Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Antibody-drug Conjugates Supply Chain Analysis
11.2 Antibody-drug Conjugates Key Raw Materials and Upstream Suppliers
11.3 Antibody-drug Conjugates Clients Analysis
11.4 Antibody-drug Conjugates Sales Channel and Sales Model Analysis
11.4.1 Antibody-drug Conjugates Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Antibody-drug Conjugates Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Antibody-drug Conjugates Distributors
12 Antibody-drug Conjugates Market Dynamics
12.1 Antibody-drug Conjugates Industry Trends
12.2 Antibody-drug Conjugates Market Drivers
12.3 Antibody-drug Conjugates Market Challenges
12.4 Antibody-drug Conjugates Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Antibody-drug Conjugates Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Antibody-drug Conjugates Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Antibody-drug Conjugates Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Antibody-drug Conjugates Sales by Region (2020-2025) & (Kg)
Table 5. Global Antibody-drug Conjugates Sales Forecast by Region (2026-2031) & (Kg)
Table 6. Global Antibody-drug Conjugates Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Antibody-drug Conjugates Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Antibody-drug Conjugates Sales Volume by Type (2020-2025) & (Kg)
Table 9. Global Antibody-drug Conjugates Sales Volume by Type (2026-2031) & (Kg)
Table 10. Global Antibody-drug Conjugates Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Antibody-drug Conjugates Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Antibody-drug Conjugates Sales Volume by Application (2020-2025) & (Kg)
Table 13. Global Antibody-drug Conjugates Sales Volume by Application (2026-2031) & (Kg)
Table 14. Global Antibody-drug Conjugates Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Antibody-drug Conjugates Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Antibody-drug Conjugates Sales by Manufacturer (2020-2025) & (Kg)
Table 17. Global Antibody-drug Conjugates Sales Share by Manufacturer (2020-2025)
Table 18. Antibody-drug Conjugates Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Antibody-drug Conjugates Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Antibody-drug Conjugates Price (2020-2025) & (USD/Kg)
Table 21. Ranking of Global Top Antibody-drug Conjugates Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Antibody-drug Conjugates Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Antibody-drug Conjugates by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody-drug Conjugates as of 2024)
Table 24. Antibody-drug Conjugates Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Antibody-drug Conjugates Market
Table 26. Manufacturers Antibody-drug Conjugates Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. ImmunoGen Company Information
Table 29. ImmunoGen Description and Business Overview
Table 30. ImmunoGen Antibody-drug Conjugates Product
Table 31. ImmunoGen Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 32. ImmunoGen Sales Proportion of Antibody-drug Conjugates by Product in 2024
Table 33. ImmunoGen Sales Proportion of Antibody-drug Conjugates by Application in 2024
Table 34. ImmunoGen Sales Proportion of Antibody-drug Conjugates by Geographic Area in 2024
Table 35. ImmunoGen Recent Developments
Table 36. Seattle Genetics Company Information
Table 37. Seattle Genetics Description and Business Overview
Table 38. Seattle Genetics Antibody-drug Conjugates Product
Table 39. Seattle Genetics Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 40. Seattle Genetics Sales Proportion of Antibody-drug Conjugates by Product in 2024
Table 41. Seattle Genetics Sales Proportion of Antibody-drug Conjugates by Application in 2024
Table 42. Seattle Genetics Sales Proportion of Antibody-drug Conjugates by Geographic Area in 2024
Table 43. Seattle Genetics Recent Developments
Table 44. Roche Company Information
Table 45. Roche Description and Business Overview
Table 46. Roche Antibody-drug Conjugates Product
Table 47. Roche Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 48. Roche Sales Proportion of Antibody-drug Conjugates by Product in 2024
Table 49. Roche Sales Proportion of Antibody-drug Conjugates by Application in 2024
Table 50. Roche Sales Proportion of Antibody-drug Conjugates by Geographic Area in 2024
Table 51. Roche Recent Developments
Table 52. Takeda Company Information
Table 53. Takeda Description and Business Overview
Table 54. Takeda Antibody-drug Conjugates Product
Table 55. Takeda Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 56. Takeda Sales Proportion of Antibody-drug Conjugates by Product in 2024
Table 57. Takeda Sales Proportion of Antibody-drug Conjugates by Application in 2024
Table 58. Takeda Sales Proportion of Antibody-drug Conjugates by Geographic Area in 2024
Table 59. Takeda Recent Developments
Table 60. North America Antibody-drug Conjugates Sales by Country (2020-2025) & (Kg)
Table 61. North America Antibody-drug Conjugates Sales by Country (2026-2031) & (Kg)
Table 62. North America Antibody-drug Conjugates Revenue by Country (2020-2025) & (US$ Million)
Table 63. North America Antibody-drug Conjugates Revenue by Country (2026-2031) & (US$ Million)
Table 64. North America Antibody-drug Conjugates Sales by Type (2020-2025) & (Kg)
Table 65. North America Antibody-drug Conjugates Sales by Application (2020-2025) & (Kg)
Table 66. Asia-Pacific Antibody-drug Conjugates Sales by Region (2020-2025) & (Kg)
Table 67. Asia-Pacific Antibody-drug Conjugates Sales by Region (2026-2031) & (Kg)
Table 68. Asia-Pacific Antibody-drug Conjugates Revenue by Region (2020-2025) & (US$ Million)
Table 69. Asia-Pacific Antibody-drug Conjugates Revenue by Region (2026-2031) & (US$ Million)
Table 70. Asia-Pacific Antibody-drug Conjugates Sales by Type (2020-2025) & (Kg)
Table 71. Asia-Pacific Antibody-drug Conjugates Sales by Application (2020-2025) & (Kg)
Table 72. Europe Antibody-drug Conjugates Sales by Country (2020-2025) & (Kg)
Table 73. Europe Antibody-drug Conjugates Sales by Country (2026-2031) & (Kg)
Table 74. Europe Antibody-drug Conjugates Revenue by Country (2020-2025) & (US$ Million)
Table 75. Europe Antibody-drug Conjugates Revenue by Country (2026-2031) & (US$ Million)
Table 76. Europe Antibody-drug Conjugates Sales by Type (2020-2025) & (Kg)
Table 77. Europe Antibody-drug Conjugates Sales by Application (2020-2025) & (Kg)
Table 78. Latin America Antibody-drug Conjugates Sales by Country (2020-2025) & (Kg)
Table 79. Latin America Antibody-drug Conjugates Sales by Country (2026-2031) & (Kg)
Table 80. Latin America Antibody-drug Conjugates Revenue by Country (2020-2025) & (US$ Million)
Table 81. Latin America Antibody-drug Conjugates Revenue by Country (2026-2031) & (US$ Million)
Table 82. Latin America Antibody-drug Conjugates Sales by Type (2020-2025) & (Kg)
Table 83. Latin America Antibody-drug Conjugates Sales by Application (2020-2025) & (Kg)
Table 84. Middle East and Africa Antibody-drug Conjugates Sales by Country (2020-2025) & (Kg)
Table 85. Middle East and Africa Antibody-drug Conjugates Sales by Country (2026-2031) & (Kg)
Table 86. Middle East and Africa Antibody-drug Conjugates Revenue by Country (2020-2025) & (US$ Million)
Table 87. Middle East and Africa Antibody-drug Conjugates Revenue by Country (2026-2031) & (US$ Million)
Table 88. Middle East and Africa Antibody-drug Conjugates Sales by Type (2020-2025) & (Kg)
Table 89. Middle East and Africa Antibody-drug Conjugates Sales by Application (2020-2025) & (Kg)
Table 90. Antibody-drug Conjugates Key Raw Materials, Industry Status and Trend
Table 91. Antibody-drug Conjugates Key Raw Materials and Upstream Suppliers
Table 92. Antibody-drug Conjugates Clients Status and Trend
Table 93. Antibody-drug Conjugates Typical Clients
Table 94. Antibody-drug Conjugates Distributors
Table 95. Antibody-drug Conjugates Market Trends
Table 96. Antibody-drug Conjugates Market Drivers
Table 97. Antibody-drug Conjugates Market Challenges
Table 98. Antibody-drug Conjugates Market Restraints
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
Table 102. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Antibody-drug Conjugates Product Picture
Figure 2. Global Antibody-drug Conjugates Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Antibody-drug Conjugates Sales Market Share by Type in 2024 & 2031
Figure 4. Adcetris Product Picture
Figure 5. Kadcyla Product Picture
Figure 6. Global Antibody-drug Conjugates Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Antibody-drug Conjugates Sales Market Share by Application in 2024 & 2031
Figure 8. Breast Cancer
Figure 9. Lymphoma
Figure 10. Antibody-drug Conjugates Report Years Considered
Figure 11. Global Antibody-drug Conjugates Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Antibody-drug Conjugates Market Size 2020-2031 (US$ Million)
Figure 13. Global Antibody-drug Conjugates Sales 2020-2031 (Kg)
Figure 14. Global Antibody-drug Conjugates Sales Market Share Forecast by Region (2020-2031)
Figure 15. Global Antibody-drug Conjugates Revenue Market Share by Region (2020-2031)
Figure 16. Global Antibody-drug Conjugates Sales Market Share Forecast by Type (2020-2031)
Figure 17. Global Antibody-drug Conjugates Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Antibody-drug Conjugates Average Selling Price (ASP) by Type (2020-2025) & (USD/Kg)
Figure 19. Global Antibody-drug Conjugates Sales Market Share Forecast by Application (2020-2031)
Figure 20. Global Antibody-drug Conjugates Revenue Market Share Forecast by Application (2020-2031)
Figure 21. Antibody-drug Conjugates Average Selling Price (ASP) by Application (2020-2025) & (USD/Kg)
Figure 22. Adcetris of Antibody-drug Conjugates Revenue Market Share by Application, 2024 VS 2031
Figure 23. Kadcyla of Antibody-drug Conjugates Revenue Market Share by Application, 2024 VS 2031
Figure 24. Global Antibody-drug Conjugates Sales Share by Manufacturer in 2024
Figure 25. Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Adcetris Market Sales Proportion by Manufacturer in 2024
Figure 27. Kadcyla Market Sales Proportion by Manufacturer in 2024
Figure 28. North America Antibody-drug Conjugates Revenue 2020-2031 (US$ Million)
Figure 29. North America Antibody-drug Conjugates Sales Market Share by Type (2020-2025)
Figure 30. North America Antibody-drug Conjugates Sales Market Share by Application (2020-2025)
Figure 31. Asia-Pacific Antibody-drug Conjugates Revenue 2020-2031 (US$ Million)
Figure 32. Asia-Pacific Antibody-drug Conjugates Sales Market Share by Region (2020-2031)
Figure 33. Asia-Pacific Antibody-drug Conjugates Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Antibody-drug Conjugates Sales Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Antibody-drug Conjugates Sales Market Share by Application (2020-2025)
Figure 36. Europe Antibody-drug Conjugates Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Antibody-drug Conjugates Sales Market Share by Country (2020-2031)
Figure 38. Europe Antibody-drug Conjugates Revenue Market Share by Country (2020-2031)
Figure 39. Europe Antibody-drug Conjugates Sales Market Share by Type (2020-2025)
Figure 40. Europe Antibody-drug Conjugates Sales Market Share by Application (2020-2025)
Figure 41. Latin America Antibody-drug Conjugates Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Antibody-drug Conjugates Sales Market Share by Country (2020-2031)
Figure 43. Latin America Antibody-drug Conjugates Revenue Market Share by Country (2020-2025)
Figure 44. Latin America Antibody-drug Conjugates Sales Market Share by Type (2020-2025)
Figure 45. Latin America Antibody-drug Conjugates Sales Market Share by Application (2020-2025)
Figure 46. Middle East and Africa Antibody-drug Conjugates Revenue Growth Rate 2020-2031 (US$ Million)
Figure 47. Middle East and Africa Antibody-drug Conjugates Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Antibody-drug Conjugates Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Antibody-drug Conjugates Sales Market Share by Type (2020-2025)
Figure 50. Middle East and Africa Antibody-drug Conjugates Sales Market Share by Application (2020-2025)
Figure 51. Antibody-drug Conjugates Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of Antibody-drug Conjugates Raw Materials by Region in 2024
Figure 53. Antibody-drug Conjugates Distribution Channels
Figure 54. Global Antibody-drug Conjugates Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global Antibody-drug Conjugates Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
